A Research Study Investigating Safety and Concentration in the Blood After One Dose Tablet of the New Medicine Monlunabant in Healthy Weight Japanese and Caucasian Men

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 9, 2024

Primary Completion Date

October 25, 2024

Study Completion Date

October 25, 2024

Conditions

Obesity

Interventions

DRUG

Monlunabant

Oral monlunabant

DRUG

Placebo (monlunabant)

Oral placebo (monlunabant)

Trial Locations (1)

Altasciences Clinical LA, Inc., Cypress